Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 23
CAR-T za zdravljenje limfomov in njihovi neželeni učinki
Lučka Boltežar, Aljoša Andlovic
Objavljeni strokovni prispevek na konferenci
Oznake: internistična onkologija;CAR-T terapija;kemoterapija;
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Limfomi prebavil
Barbara Jezeršek Novaković, Lučka Boltežar
Druge monografije in druga zaključena dela
Oznake: limfomi;imunoterapija;limfoproliferativne bolezni;
Leto: 2025 Vir: Onkološki inštitut Ljubljana (OI)
Granulomatosis after autologous stem cell transplantation in nonHodgkin lymphoma
Lučka Boltežar, Ivana Žagar, Barbara Jezeršek Novaković
Pregledni znanstveni članek
Oznake: granulomatosis;nonHodgin lymphoma;PET-CT;differential diagnosis;
Sarcoidosis before and after treatment of malignancy is an important differential diagnosis that has to be distinguished from lymphoma. Patients and methods. Hodgkin lymphoma, diffuse large B-cell lymphoma and aggressive follicular lymphoma are being staged and treatment effect is evaluated with PET ...
Leto: 2016 Vir: Onkološki inštitut Ljubljana (OI)
Ocular adnexal lymphoma - a retrospective study and review of the literature
Lučka Boltežar, Danijela Štrbac, Jože Pižem, Gregor Hawlina
Izvirni znanstveni članek
Oznake: ocular adnexal lymphoma;orbital lymphoma;conjunctival lymphoma;
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Trends in specialized palliative care referrals at an oncology center from 2007 to 2019
Lučka Boltežar, Barbara Jezeršek Novaković, Maja Ebert Moltara
Izvirni znanstveni članek
Oznake: paliativna oskrba;primarni rak;zgodnje napotitve;palliative care;primary site of cancer;early referral;
Leto: 2021 Vir: Onkološki inštitut Ljubljana (OI)
Long-term outcome of multilayer flow modulator in aortic aneurysms
Karlo Pintarić, Lučka Boltežar, Nejc Umek, Dimitrij Kuhelj, Dimitrij Kuhelj
Izvirni znanstveni članek
Oznake: multilayer flow modulator;aortic aneurism;long-term follow up;volumetric measurements;
ckground. This retrospective study investigated the efficacy of endovascular treatment with multilayer flow modu-lators (MFMs) for treating aortic aneurysms in high-risk patients unsuitable for conventional treatments.Patients and methods. Conducted from 2011 to 2019 at a single center, this retrosp ...
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma
Matej Panjan, Lučka Boltežar, Srdjan Novaković, Ira Koković, Barbara Jezeršek Novaković
Izvirni znanstveni članek
Oznake: clinical characteristics;follicular lymphoma;t(14;18) translocation;
Background: t(14;18)(q32;q21) translocation is an important genetic feature of follicular lymphoma resulting in antiapoptotic B-cell lymphoma 2 (BCL2) protein overexpression. On chromosome 18 breakpoint-site variation is high but does not affect BCL2. Breakpoint most commonly occurs at major breakpo ...
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
ǂThe ǂprognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified
Teja Čas, Simona Miceska, Gorana Gašljević, Lučka Boltežar, Veronika Kloboves-Prevodnik
Izvirni znanstveni članek
Oznake: diffuse large b-cell lymphoma;immunohistochemistry;cytopathology;
Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) is the most common type non-Hodgkin’s lymphoma, where the treatment of relapsed/refractory cases is the major challenge. Programmed cell death protein 1 (PD-1) and its ligand PD-L1 play a crucial role in the negative regulation of t ...
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Ali visoko maligni B-celični limfomi, dvojni ekspresorji, res potrebujejo intenzivnejšo kemoterapijo
Lučka Boltežar, Samo Rožman, Gorana Gašljević, Biljana Grčar-Kuzmanov, Barbara Jezeršek Novaković
Objavljeni znanstveni prispevek na konferenci
Oznake: limfomi;kemoterapija;onkološko zdravljenje;
Velikocelični B limfomi z BCL2 in BCL6 preureditvijo so imenovani "double-hit" oziroma "triplehit" limfomi, z imunohistokemično ekspresijo pa dvojni ekspresorji (DE) in vsi imajo slabšo prognozo od klasičnih velikoceličnih limfomov B. Opravljena je bila študija vseh bolnikov z visoko malignimi B lim ...
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
Do double-expressor high-grade B-cell lymphomas really need intensified treatment
Lučka Boltežar, Samo Rožman, Gorana Gašljević, Biljana Grčar-Kuzmanov, Barbara Jezeršek Novaković
Izvirni znanstveni članek
Oznake: limfomi;dvojno izražen limfom;onkologija;lymphoma;double-expressor lymphoma;oncology;
High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements are known for their aggressive clinical course and so are the ones with MYC and BCL2 protein overexpression. The optimal therapy for these lymphomas remains to be elucidated. A retrospective analysis of all diffuse large B-cell ...
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Št. zadetkov: 23
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: